Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
CQ topics
1
How to study guidelines?
1. ESC or ACC?
-If you have enough time, study ESC very well, then have a rapid
look on ACC(recommendations only not full text(
3. -Always start first with tables and algorithms, finish them all first,
study them very well, then go to full text as a last step. When you
do this, you will find the text is easier and will answer the
questions that have been raised by your mind after you have
studied the tables
5. When to study Full text, you have to Write the most important
notes in a separate paper by yourself
Final revision before exams, you can revise the tables, algorithms
and your notes about the full text
2
7. In the ESC guidelines, you will find what's new in these guidelines,
read it rapidly. It is mainly done for those who have read the old
guidelines and they want rapid update. But at exam level, you need
to know mainly the new recommendations
As in MCQ, he can give you statement and gives you the above
options
9. You should know very well what is class I and what is class III
recommendations, these are most important, Followed by class II
indications
10.In the beginning of each ESC guidelines, you will find a list with
all trials included in these guidelines
This list is very important, as it will help you you to know the
important trials
12.-Start with the most recent guidelines as these guidelines will not
change before exams
https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines
https://www.acc.org/guidelines
3
Peripartum cardiomyopathy (PPCM(
4
Takotsubo cardiomyopathy
(Brocken heart syndrome(
1. More common in post-menopausal female
2. Related to severe emotional stress
3. Pathogenesis is related to catecholamine toxicity
4. Moderate Troponin elevation despite extensive ECG change and
Echo findings
5. RWMA in echo involving multiple coronary territories
6. RWMA most commonly involved apex and adjoining apical
segments, less commonly mid myocardial segments, least
commonly involve basal segments
7. Normal coronary angiography or discrepancy between RWMA
findings in echo and coronary angiography findings
8. No late gadolinum enhancement in cardiac MRI
9. Prolonged QT more than 500 msec
10.Usually reversible LV function
11.Most common finding in Left ventriculography is apical ballooning
12.ECG changes include ST elevation or depression
5
Novel oral anticoagulants (NOACs(
1. Other names:
6
16.As a general rule, NOACs are at least as effective as Warfarin and
they are more safe as regard Bleeding risk
17.The risk of Hemorrhagic stroke or cerebral hemorrhage is low with
all NOCAs when compared to Warfarin
18.The only 2 NOCAs that showed superiority over warfarin in stroke
risk reduction are apixaban 5 mg twice and Dabigatran 150mg
twice
19.Other NOACs have a comparable stroke risk reduction VS.
Warfarin
20.Dabigatran is associated with reduction of vascular mortality,
Apixaban is associated with reduction of all-cause mortality,
edoxban is associated with reduction of Cardiovascular mortality
21.Rivaroxaban should be given with meal
22.Highest renal excretion with dabigatran, lowest renal excretion
with apixaban
23.Trials of NOACs with P2 Y12 inhibitors
-Redual PCI(dabigatran(
-Pionner AF(Rivaroxaban(
-Augustus(apixaban(
-Entrust(Edoxaban) (ongoing(
24.Trials of NOACs in A-Fib
-Rely (dabigatran(
-Rocket(Rivaroxaban)
-Aristotle (Apixaban(
-Engage (Edoxaban(
25.Trials of NOACs in venous thromboembolism
-Recover(Dabigatran(
-Einstein(Rivaroxaban(
-Amiplify(Apixaban(
26.No need for concomitant treatment with parenteral anticoagulant
upon starting with apixaban or Rivaroxaban in treatment of venous
thromboembolism. Instead, you can give apixaban 10mg twice for
1 week then 5 mg twice daily thereafter And Rivaroxaban 15mg
twice daily for 3 weeks then 20mg once daily there after.
7
Tips and tricks in management of
Dyslipidemia
1. Atherogenic lipids include LDL and VLDL
2. Apo B is the lipoprotein included in the LDL and VLDL
3. Apo B and Non HDL cholesterol are more representative for
atherogenic risk more than LDL as both of them reflect LDL plus
VLDL
4. Targets in management of dyslipidemia are
LDL
Then non HDL-cholesterol
Then Apo B
5. Lipoprotein(a) is modified form of LDL, level 50 mg or more is
considered risk enhancer, it should be requested in patients with
family history of premature CAD or personal history of
unexplained CAD
6. According to ESC guidelines
-Apo B Target
Less than 80 mg in very high cardiovascular
Less than 100 in high cardiovascular risk
8
7. According to American guidelines, Patients with 10 year risk of
ASCVD 7.5 % and triglycerides level from 175-499 mg are
indicated for Statin
8. Primary prevention include:
Patients with DM
Patients with LDL level 190 mg or more
Patients with high CVD risk
9
Cardiovascular benefits of
Antidiabetic drugs
A-Insulin dependent
A-Insulin dependent:
#Insulin secretagouges:
1. -Sulphonylurea:
Glimepiride (Amaryl(
Glibenclamide (Doanil(
Gliclazide (Diamicron(
-Incretins include:
Gastric inhibitory polypeptide (GIP(
Glucagon like peptide (GLP(
10
-Incretin based therapy include:
-Semagultide
-Albiglutide
-Liraglutide(Victoza(
-Exenatide
-Linagliptin(Trajenta(
-Vildagliptin(Galvus (
-Sitagliptin(Januvia)
3. Meglitinide:
Repaglinide (Novonorm(
#Insulin sensitizer:
*Biguanides:
*Thiazolidindione:
Acrabose (Glucobay (
11
#Glucose reabsorption inhibitors:
-Dapagliflozin (Forxiga(
-Empagliflozin (Jardiance)
-Canagliflozin (Invocana (
GLP-1agonist
SGLT2 inhibitors
12
-DPP4 inhibitors are neutral as regards Cardiovascular benefits
Except saxagliptin which increase HF hospitalization(Salvos trial)
13
Heart failure with preserved EF (HFpEF(
1. Definition:
*Typical symptoms and signs of HF
*Echo:
2. Pathophysiology:
Related mainly to failure of relaxation and abnormal
calcium handling during the cardiac cycle
3. Type of patient:
-More in elderly
-More in female
-Typically associated with AF, hypertension, LVH,
CAD, Obesity, DM, CKD
4. Diagnosis:
*Echocardiography
14
*Hemodynamic study for assessment of filling pressure,
Confirmation of pulmonary pressure and Fluid challenge to
unmask symptoms in borderline cases
*HFpEF score
5. Management:
-Control of HTN
-Control of DM
-Rhythm control for A-Fib
-Proper Management of CAD(Revascularization may be
Required(
C-Medical
*ACEI/ARBs
*ARNI:
-Failed in paramount trial(only improvement in
NYHA class, LA size, NT pro BNP)
*Beta blockers:
15
*Spironolactone may be considered (based on American
Side of TOP-CAT(
D-Gene therapy:
-Parvalbumin(calcium buffer)
E-Device therapy:
Interatrial shunt device (based on Reduce-LAP trial)
to create Interatrial communication allow only left to
right shunt to Decrease Left atrial pressure
16
PCSK9 inhibitors
9. Trials:
10.Trade name
-Repatha(Evolocumab)
-Praluent(Alirocumab(
17
Angiotensin receptor-neprilysin inhibitor
(ARNI(
1. ARNI is considered a breakthrough in management of heart failure
2. ARNI is composed of 2 drugs:
Neprilysin inhibitor:Sacubitril
4. Mechanism of action:
18
6. Evidence of use:
7. Guidelines:
8. Contraindications of ARNI:
-History of angioedema
-Liver cirrhosis Child C
-Pregnancy
-Hyperkalemia
9. Dose modifications:
19
10.Standard dose is 100 mg twice daily, Can be increased after 2-4
weeks interval to 200 mg twice daily
20
Cardiac amyloidosis
1. Types:
4. Echo:
5. -Diagnosis:
21
-Technitium scintigraphy can be used for diagnosis of TTR related
amyloidosis
6. Associated Features:
7. Treatment:
I- Tafamidis is now approved for treatment of Familial type with
autonomic neuropathy based on ATTR-ACT trial, Decrease all-
cause mortality and HF hospitalization.
-There are 2 preparations: Vnydaqel and Vyndamax
Both are contraindicated in Pregnancy
III- Anticoagulation:
For AF regardless CHADS-VASc score due to high incidence of
LAA thrombus due to marked reduction of LA function
22
10 points to remember about role of
prophylactic revascularization before
elective non cardiac surgery
5- Most of the patients did not exhibit plaque fissuring and only one-third
had an intracoronary thrombus.
24
CQ pearls
25
Cardiology pearls (part I)
A-Hypovolemic shock:
Bleeding from sheath or retroperitoneal hematoma
B-Cardiogenic shock:
Acute instent thrombosis
C-Anaphylactic Shock:
From contrast
26
Cardiology pearls (Part II)
1. Any hospitalized patient who develop new onset AF during
hospital stay, you should suspect Pulmonary embolism
2. Enoxaprin is contraindicated if GFR is less than 15 m and if
GFR is from 15-30 we give 1mg/Kg every 24 hours as a
therapeutic dose
3. Any wide complex tachycardia in patient with ischemic
heart disease should be managed as VT until proved other
wise
4. Causes of very high ESR(more than 100 In first hour)
includes:
-TB
-Connective tissue disorders
-Malignancy
5. D-Dimer is a good negative test in pulmonary embolism but
not specific
6. Uro-sepsis is the most common cause of delirium in elderly
7. Anemia in old age carries the possibility of malignancy and
ideally upper and lower GIT endoscopy should be done
8. It is recommended to do lipid profile within 48 hours of
onset of ACS as after that there is a possibility of false low
cholesterol levels due to enhanced sympathetic activity and
lipolysis
9. You can calculate the LDL level from this equation
(LDL=Total cholesterol -(HDL + Triglycerides/5(
10.You can calculate the creatinine clearance from this equation
(140-ageX weight(/72X serum creatinine ,and multiply by
0.85 if female
27
Cardiology pearls (Part III(
1. Metolazone is the only thiazide that can be used in Renal
impairment
2. It better to avoid imipenem(Tienam) and
levofloxacin(Tavanic) in elderly as the former can causes
convulsions and the latter can precipitate encephalopathy
3. The most common congenital heart disease is bicuspid aortic
valve
4. Bicuspid aortic valve can be associated with
-Aortopathy and aortic aneurysm
-Aortic coarctation
-Aneurysm in circle of Willis
5. Never wait for cardiac enzymes in patient with STEMI
6. Congenital complete heart block carries the best prognosis
among the all causes of CHB and sometimes can be
managed conservatively for years
7. Always check for BP equality on both sides in patient with
acute Coronary syndromes to exclude dissection
8. Always ask about history of sildenafil use before using
nitrates
9. Never use sublingual Nifedipine
10.Do not diagnose Rheumatic fever based on arthralgia that is
associated with elevated ESR , You should use modified
Jones criteria
28
Cardiology pearls (Part IV(
1. Diagnosis of DM:
-FBS more or equal to 126 mg/dl in two separate occasions
Or
-Postprandial blood glucose more or equal to 200mg /dl on
two separate occasions
Or
-HbA1c is more or equal to 6.5%
Or
-Random blood glucose more or equal to 200 mg/dl in
Presence of symptoms (Polyurea, polyphagia and loss of
weight(
2. Targets in DM control
-Pleural fluid LDH more than 2/3 of the upper normal value
29
7. Drop out of the interatrial septum in Apical 4 chamber is not
suggestive of ASD except after confirmation with color flow
across and further assessment in subcostal view
8. Dynamic LVOT obstruction with significant LVOT gradient
could be seen in elderly dehydrated tachycardiac patients
(especially if hypertensive with LVH and small LV cavity( .
After rehydration and control of HR, The gradient across the
LVOT disappear
9. Verapamil increase the digitalis toxicity and it is better to
combine Diltiazem rather than verapamil with digitalis
10. Digoxin toxicity can occur despite of normal digoxin level
and can be diagnosed only based on clinical basis and ECG
30
Cardiology pearls (Part V(
10.The Safest drugs that can be given for patients with pericarditis and
ACS are Ibuprofen (as it increases Coronary blood flow) or high
dose acetyl salicylic acid
31
Cardiology pearls (part VI(
33
Q: ACE inhibitor is a good option for management of
hypertension in patients with aortic coarctation?
Answer:
True or false:
Risk of Intracerebral hemorrhage is more with
streptokinase when compared to alteplase
Answer: false
34
True or false:
35
Q: Causes of type 2 MI?
Answer: According to ESC guidelines for fourth universal
definition of MI 2018
36
Q: Triad for cholesterol embolism? (Trash foot(
Answer:
-The term acute myocardial infarction should be used when there is acute
myocardial injury with clinical evidence of acute myocardial ischaemia
and with detection of a rise and/or fall of cTn values with at least one
value above the 99th percentile and at least one of the following:
37
Case scenario to explain myocardial injury vs.
myocardial infarction
You have been consulted to review a 35 year old male patient, chronic
kidney disease on regular dialysis, hypertension, and blood pressure
160/100.
The resident in charge consulted you as he found that his troponin is
positive. ECG was normal apart from LVH with non- specific ST-T wave
changes. Cardiac wise, the patient is asymptomatic.
How will you proceed?
My approach (according to the ESC guidelines for fourth universal
definition of MI, 2018)
Few steps
1-Positive cardiac biomarker is considered cardiac injury VS. Myocardial
infarction
2-If cardiac biomarker is only positive with no evidence of ischemia by
symptoms; ECG changes; Echo, then it will be considered myocardial
injury
3-Myocardial injury is 2 types: Acute or chronic
4-To differentiate between both, you should ask for second set
If there is at least 20% change, then it is acute injury
If no change or change less than 20%
Then It is Chronic injury
Back to our case
The only available data are symptoms, ECG and one set of enzymes
The best approach is
1-Serial ECG
2-Second set troponin
3-Echo
The investigations were done and showed
1-No significant change of cardiac troponin after 6 hours
2-Echo: hypertensive heart diseases
3-No dynamic ECG changes
Final diagnosis:
Chronic myocardial injury secondary to uremic toxins and hypertension
Management:
BP control, proper management of the renal condition
38
Q: Tamponade after cardiac surgery and Pericardial Fluid
analysis was rich in triglycerides?
Answer: Iatrogenic thoracic duct injury with chylopericardium
II-Carotid
1-AS: Decrease
2-HOCM: increase
39
Q: Patient presented to non-PCI capable facility with acute
chest pain, diagnosed as STEMI. Onset of chest pain since 2
hours, transfer to primary PCI will take 90 minutes. How
would you treat?
Answer:
The accepted delay for primary PCI in early presenters within the first 3
hours from the chest pain onset is only 60 minutes, not the standard 120
minutes. Reference: ESC STEMI guidelines 2017
Q: True or false?
Statin and antiplatelet therapy are indicated in all patients
with lower extremity arterial disease (LEAD) or carotid
disease (symptomatic or asymptomatic)
Answer: False
40
Q: How to use high dose aspirin for treatment of post
MI pericarditis without losing its antiplatelet action?
Answer:
Dose of Aspirin up to 1500 mg/day is effective as antiplatelet and
anti -inflammatory (ESC guideline 2015 in treatment of
pericarditis)
41
Q: What is the safest Fibrinolytic therapy during pregnancy
and why?
Answer: Alteplase as it does not cross the placenta
Pericardial effusion
Ascites
42
Q: Enumerate Uses of thrombolytic therapy in Cardiology?
1. STEMI
2. Pulmonary embolism
3. DVT catheter based
4. Peripheral arterial thrombosis (catheter based)
5. Prosthetic valve thrombosis
6. Acute ischemic stroke
Answer:
-2:1 AV block is either intranodal (in the AV node) or infra nodal
1. Narrow complex
2. Improve with exercise and atropine
3. Worsened with carotid sinus massage
1. Wide complex
2. Worsened with atropine and exercise and atropine
3. Improve with carotid sinus massage
43
Q: What is the first choice of Antidiabetic drugs in cardiac
patients?
Answer: Metformin
44
Q: Patient was maintained on Ticagrelor, can we shift
to maintenance clopidogrel therapy?
45
Q: Triad for fat embolism?
Answer: Skin rash, disturbed conscious level, respiratory distress
-Age above 70
-Weight less than 60 kg
-History of TIA or stroke
-Medically managed ACS patients
-For people >80 years who have not yet received treatment for their
BP, treatment is recommended when their office SBP is >160
mmHg, provided that the treatment is well tolerated (Class I C)
*ESC guidelines for hypertension, 2018.
Answer:
47
Q: What is the possible explanation for this finding?
Q: When to use FFR cut off value 0.8 and when to use cut
off value 0.75?
Answer: To improve prognosis, in patients with stable CAD, It is
justified to do revascularization if Left main or proximal LAD 50%
stenosis with FFR is 0.8 or less
Or any other vessel with FFR with less than 0.75
Aortic plaque
PAD
Previous MI
48
Q: What is meant by "S" in CHADS-VASc score?
Answer:
1. HOCM
2. AS
49
Q: True or false?
Verapamil is a good option for patients with positive vaso-reactivity test
and pulmonary arterial hypertension?
Answer:
50
Q: What are the Features of non- bacterial thrombotic
endocarditis (Libman sacks endocarditis)?
Q: True or false?
Nebivilol and Carvedilol are a good choice for patient with
HOCM?
Answer:
False. The recommended beta blocker in patients with HOCM are non-
vasodilatory beta blockers (eg ; bisoprolol or metoprolol)
51
Q: Mention the conditions in which you should give
anticoagulation in AF regardless of CHADS-VASc score
1. HCM
2. Fontan
3. Systemic RV
4. Intra-cardiac repair in congenital heart disease
5. Cyanotic heart disease
6. After ablation for 8 weeks
7. After cardioversion for 4 weeks
8. Mechanical prosthesis
9. Moderate or severe MS
10. Anticoagulation for other indications(DVT, PE, LV thrombus, etc(
11.Thyrotoxicosis(in some papers)
12. Amyloidosis
studied in ATLAS trial (post ACS) and Compass trial (in patient with
Compass Conclusion:
52
Q: What are the Eligibility criteria for NOACS?
Answer: according to EHRA
53
54
55